In this August 4 segment, Michaele Linden-Johnson, Director of Clinical Trials and Business Development, MCA, discusses MCA’s new Clinical Trail Academy that seeks grow the clinical research workforce and the number of outpatient clinics conducting clinical research in El Paso, Texas and Las Cruces, New Mexico.
In this July 12, 2021 interview, Sans Thakur, Chief Growth Officer, Medable, clears up some of the confusion surrounding the term “decentralized clinical trials,” explains why physical sites remain a critical component in the trial infrastructure, and how savvy sites can leverage new tools and technology to improve efficiency.
In this July 12, 2021 interview, Jordan Story, Business Development Manager, Wake Research, discusses how forging strong professional relationships can help alert sites to identifying and winning new trials best matched to their strengths as an operation.
In this July 8, 2021 interview, Mary Veazie, Executive Director, UTMD Anderson Cancer Center, discusses the shortage of financial personnel in the clinical trial workforce, why it offers an attractive career path, and reflects on her own rewarding career.
In this July 1, 2021 interview, Merck leaders discuss how the company’s approach to promoting patient diversity includes confronting root cause challenges in trial design and elsewhere that have been obstacles to attaining wider diversity in the patient population.